SAMe Enteric Coated.

SAMe donates its methyl group and becomes homocysteine by way of SAH, and B12-dependent methionine synthase is the enzyme that returns homocysteine to methionine. Without adequate B12 the cycle backs up at that step.

5-MTHF is the methyl donor that methionine synthase transfers through B12 to homocysteine. It is the direct upstream partner for regenerating the methionine that SAMe is built from.

Cystathionine beta-synthase and cystathionine gamma-lyase both need pyridoxal-5-phosphate to move homocysteine down the transsulfuration branch to cysteine. That branch is the other exit from the SAMe cycle.

Betaine-homocysteine methyltransferase remethylates homocysteine using betaine rather than folate and B12. It gives the cycle a second exit and spares the folate-dependent route.

Choline is oxidised to betaine, the methyl donor for the alternative remethylation route. It is also the endpoint of PEMT, one of the larger consumers of SAMe methyl groups.

Guanidinoacetate methyltransferase is among the largest single consumers of SAMe in the body. Supplying creatine directly lowers demand on that step and leaves more methyl capacity for other reactions.

Glycine N-methyltransferase consumes surplus SAMe by methylating glycine to sarcosine, which is how the body buffers an excess methyl load. Adequate glycine keeps that buffer available.

Methionine adenosyltransferase builds SAMe from methionine and ATP, and it uses magnesium-bound ATP as substrate. Magnesium status therefore sets the rate of endogenous SAMe formation.

The transsulfuration branch downstream of SAMe produces cysteine, the rate-limiting amino acid for glutathione synthesis. NAC feeds that same node directly and lowers the draw on the methylation pathway.

MTHFR carries an FAD cofactor derived from riboflavin and generates the 5-MTHF that feeds remethylation. Low riboflavin slows the folate arm of the cycle that regenerates methionine.

Both methionine synthase and betaine-homocysteine methyltransferase hold the methyl acceptor at a zinc centre. Zinc status therefore sits underneath both remethylation routes.

SAMe raises monoamine turnover through methylation-dependent steps while 5-HTP feeds serotonin synthesis directly. Stacking them adds on the same signalling arm, so a formulator should account for the combined load rather than dosing each as if it stood alone.

Hyperforin slows monoamine reuptake while SAMe acts on methylation-dependent synthesis and receptor handling. The two effects add on the same pathway, and St John's wort also induces CYP3A4, which changes exposure to other co-formulated actives.

SAMe methylates phosphatidylethanolamine to phosphatidylcholine, a membrane step that supports normal bile secretion. TUDCA acts on the bile acid pool itself, so the two reach bile physiology from separate directions.

Silymarin acts on membrane stabilisation and Nrf2-linked enzyme expression, while SAMe feeds the cysteine supply that glutathione synthesis depends on. Long-standing formulation practice pairs them for that reason.

SAMe is made in the body from methionine and ATP by methionine adenosyltransferase, so methionine is the direct precursor of the molecule being supplemented. Supplying the finished product bypasses that step, while methionine availability still governs how much SAMe the liver regenerates on its own. The two sit at consecutive points on one pathway rather than doing the same job.

Once SAMe donates its methyl group it becomes S-adenosylhomocysteine and then homocysteine, and one exit route for homocysteine is transsulfuration to cysteine, the rate-limiting input to glutathione synthesis. That makes SAMe an upstream contributor to the same thiol pool glutathione occupies. The pathway link is textbook; it is not a claim that oral glutathione and SAMe have been trialled together.

Cysteine is the product of the transsulfuration arm that homocysteine enters after SAMe has been used as a methyl donor. Providing cysteine directly reduces the demand on that arm, which is the same logic that puts SAMe and sulfur amino acids in the same conversation. Nothing here has been measured as a combination in people.

Taurine sits downstream of cysteine, which is itself downstream of the homocysteine produced when SAMe donates a methyl group. Sulfur that enters through methionine and passes through SAMe can end up in taurine. This is pathway placement, not an outcome claim for the pair.

Decarboxylated SAMe donates the aminopropyl group that converts putrescine to spermidine and spermidine to spermine, which is the second major fate of SAMe alongside methylation. Polyamine synthesis consumes SAMe rather than recycling it. Anyone reading SAMe purely as a methyl donor is missing half of what the molecule is spent on.

The PEMT route builds phosphatidylcholine by three successive SAMe-dependent methylations of phosphatidylethanolamine, and that route is one of the largest single consumers of SAMe in the liver. Supplying phosphatidylcholine directly lowers the methylation demand placed on the SAMe pool. The relationship is quantitative in biochemistry terms and has not been trialled as a supplement pair.

Two steps of coenzyme Q10 biosynthesis are SAMe-dependent O- and C-methylations carried out by COQ3 and COQ5. That makes methyl group availability part of how the body builds its own CoQ10. It says nothing about whether taking both together changes any measured outcome.

The final step of melatonin synthesis is a SAMe-dependent methylation of N-acetylserotonin by acetylserotonin O-methyltransferase. Melatonin therefore cannot be assembled without a methyl donor. The link is a synthesis step, not a sedative interaction, and no combination trial supports dosing them together.

Endogenous carnitine synthesis begins with SAMe-dependent trimethylation of protein-bound lysine to trimethyllysine. Three methyl groups per carnitine molecule come out of the SAMe pool. This is an upstream dependency of carnitine synthesis rather than a co-supplementation finding.

Sulfite oxidase, the enzyme that finishes the oxidation of sulfur coming out of cysteine catabolism, requires a molybdenum cofactor. Sulfur amino acid load that passes through the SAMe and transsulfuration route ends at that enzyme. Cofactor sufficiency supports the normal handling of that sulfur; it is not a reason to expect an added effect.

Serine donates the one-carbon unit that loads the folate cycle through serine hydroxymethyltransferase, and that cycle is what remethylates homocysteine back to methionine so SAMe can be regenerated. Serine supply therefore sits behind the recycling half of the methylation cycle. The relationship is established biochemistry with no combination trial attached.